What IDEX's latest 10-Q says: 6 signals

IDEX filed its latest 10-Q with the SEC on Jul 29, 2026. It discusses acquisition completed, automation investment and board change.

Public (IEX)Machinery Manufacturing5,001 to 10,000 employeesidexcorp.comLinkedIn

Filed: Jul 29, 2026
Filings: 2
Signals: 11

10-Q · latest 10

What IDEX's 10-Q filings say

10-Q
Filed Jul 29, 2026 · 6 signals
SEC EDGAR
- Automation investmentPositive
  IDEX boosts capital expenditures 40% to $40.7M, targeting productivity and system upgrades.
  IDEX increased capital expenditures by $11.6M year-over-year, with spending focused on machinery, business system technology, and equipment replacement to drive productivity.
  $40.7M
  Capital expenditures in the first six months of 2026
- Acquisition completedNeutral
  Recent acquisition in HST segment is now in active post-merger integration phase.
  A recent acquisition is contributing 2% to the Health & Science Technologies (HST) segment's sales growth, indicating the company is in a critical post-merger integration phase.
  2%
  Sales growth contribution from a recent acquisition to the HST segment.
- Market expansionPositive
  IDEX boosts CapEx by 40% to $40.7M, funding new facilities and business systems.
  IDEX significantly increased capital expenditures by $11.6 million in H1 2026, signaling major investment in expanding its operational footprint and upgrading technology.
  $40.7M
  Capital expenditures for the first six months of 2026.
  business system technology
- Capex increasePositive
  IDEX increases capital expenditures to $40.7M in H1 2026, up $11.6M year-over-year.
  The company significantly increased spending on machinery, equipment, and business system technology to support growth and productivity.
  $40.7M
  Capital expenditures for the first six months of 2026.
- Board changePositive
  IDEX has $774.7M remaining in its board-authorized share repurchase program.
  The Board of Directors has a massive, active share repurchase authorization with $774.7 million remaining.
  $774.7M
  Remaining share repurchase authorization as of June 30, 2026.
- Litigation materialNegative
  IDEX and eight subsidiaries are defendants in numerous asbestos-related personal injury lawsuits.
  The company is managing a significant number of asbestos-related claims, creating a long-term legal and administrative burden.
10-Q
Filed Apr 29, 2026 · 5 signals
SEC EDGAR
- Governance changeNeutral
  IDEX discloses severance agreement with executive Roopa Unnikrishnan dated Feb 27, 2026
- Platform strategyPositive
  IDEX increases Q1 capital expenditures to $17.7M for technology, productivity, and facilities.
  Capital expenditures rose from $14.3M in the prior year quarter, with funds allocated for machinery, business system technology, and new facilities.
  $17.7M
  Capital expenditures in Q1 2026
- Capex increasePositive
  Capital expenditures increased 24% YoY to $17.7M in Q1 2026
  The company increased spending on machinery, equipment, and business system technology by $3.4M compared to the prior year.
  $17.7M
  Q1 2026 capital expenditures
  23.8%
  YoY increase in Q1 capital expenditures
- Margin pressureNegative
  Fluid & Metering Tech segment EBITDA margin declined due to unfavorable mix and volume deleverage
  The FMT segment's profitability is being squeezed by a poor product mix and lower sales volumes, with margins declining 10 bps.
  -0.1%
  Adjusted EBITDA margin change (10 bps) for the Fluid & Metering Technologies segment

Showing 10 of 11 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

IDEX earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call date	Period	What the company said
Oct 29, 2025	Q3 FY2025	Driving over $60M in annual savings via platform optimization and cost containmentA major corporate initiative is focused on delivering over $60 million in savings through platform optimization and cost containment. This signals a strong appetite for efficiency-driving technologies and services across their business units.
Oct 29, 2025	Q3 FY2025	Driving over $60M in annual savings via platform optimization and cost containmentThe company is executing a major cost-saving program, yielding $17M in Q3 and targeting over $60M for the year. This intense focus on efficiency and cost reduction creates opportunities for vendors with solutions that improve productivity, automate processes, or lower operational expenses.
Oct 29, 2025	Q3 FY2025	Actively investing in and winning business for data center solutionsExecutives highlighted data centers as a top driver of orders and sales, with specific investments in power generation and cooling applications. This indicates a strong budget and focus on this high-growth market.
Oct 29, 2025	Q3 FY2025	Investing heavily in building out "Intelligent Water" software and analytics platformThe company is expanding its intelligent water platform, their most software-intensive business, through acquisitions and internal development. This creates opportunities for vendors in data capture, analytics, and software to support this strategic initiative.
Oct 29, 2025	Q3 FY2025	Shifting from large M&A to focus on strategic bolt-on acquisitionsLeadership is pausing large acquisitions to focus on optimizing recently acquired platforms and pursuing smaller, strategic bolt-on deals. This creates opportunities for vendors offering efficiency tools, integration services, and targeted technologies.
Oct 29, 2025	Q3 FY2025	Health & Science segment driving growth with 10% organic sales increaseThe Health & Science Technologies (HST) segment is the company's primary growth driver, with 10% organic sales growth fueled by pharma, data centers, and life sciences. This segment has budget and momentum, making it a prime target for new vendor solutions.

Signal API · MCP

Track IDEX with the Signal API

One POST /v1/companies/enrich call with idexcorp.com returns IDEX 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"idexcorp.com","signal_types":["sec-10q"],"limit":20}'

Same industry

Questions about IDEX 10-Q

When did IDEX file its latest 10-Q?

IDEX filed its latest 10-Q on Jul 29, 2026. The one before it was filed on Apr 29, 2026.

What did IDEX disclose in its latest 10-Q?

From the filing dated Jul 29, 2026: IDEX boosts capital expenditures 40% to $40.7M, targeting productivity and system upgrades.

What did IDEX say on its recent earnings calls?

Q3 FY2025: Driving over $60M in annual savings via platform optimization and cost containment (dated Oct 29, 2025).

Where can I read IDEX's 10-Q filing?

The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/832101/000083210126000022/iex-20260630.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of Sep 30, 2026.

How this data is built →Get it from the Signal API →

What IDEX's latest 10-Q says: 6 signals

What IDEX's 10-Q filings say

IDEX earnings headlines

Track IDEX with the Signal API

10-Q at related companies

Questions about IDEX 10-Q